Sort
50,496 grants matching “lung cancer”
Leveraging Quantitative Imaging from Lung Cancer Screening to Create Tools to Confront COPD
$672,974Meilan K Han · University Of Michigan At Ann Arbor · R01 · FY2025 · HL
CANCER-ASSOCIATED MACROPHAGELIKE (CAML) CELLS TO ENHANCE DETECTION OF EARLY-STAGE LUNG CANCER AND RELAPSE AFTER DEFINITIVE TREATMENT
$672,969The Institute For Cancer Research · · FY2018 · Department of the Army
Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners
$672,921Philip Taylor · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER
$672,912University Of Alabama At Birmingham · N01 · FY2000 · CN
Early Diagnosis of Pancreatic Cancer
$672,897Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2007 · CA
Harm Reduction for Smokers with Mental Illness: RCT of E-cigarette Provision with or without Behavioral Support to Boost Switching
$672,894Sarah Ilana Pratt · Dartmouth-Hitchcock Clinic · R01 · FY2025 · DA
Investigating the therapeutic potential of a novel glutamine antagonist in KEAP1 mutant lung cancer
$672,853Thales Papagiannakopoulos · New York University School Of Medicine · R01 · FY2024 · CA
Targeted cell-depleting immunotherapy for TB and HIV
$672,796William Ramses Bishai · Johns Hopkins University · R01 · FY2020 · AI
Targeted cell-depleting immunotherapy for TB and HIV
$672,796William Ramses Bishai · Johns Hopkins University · R01 · FY2023 · AI
Targeted cell-depleting immunotherapy for TB and HIV
$672,796William Ramses Bishai · Johns Hopkins University · R01 · FY2021 · AI
Targeted cell-depleting immunotherapy for TB and HIV
$672,796William Ramses Bishai · Johns Hopkins University · R01 · FY2024 · AI
Targeted cell-depleting immunotherapy for TB and HIV
$672,796William Ramses Bishai · Johns Hopkins University · R01 · FY2022 · AI
In vivo prime editing for precision cancer mouse models
$672,615Wen Xue · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · CA
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV
$672,541Corinne E. Joshu · Johns Hopkins University · R01 · FY2024 · CA
Novel Lymphocyte Chemoattractant Receptor and Ligand
$672,536Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2025 · AI
Ultra-sensitive mass spectrometry-based immunopeptidomics using digital microfluidics.
$672,371Etienne Caron · Yale University · R61 · FY2025 · CA
Pain and Symptoms of Cancer: Assessment and Treatment
$672,360University Of Texas Md Anderson Can Ctr · R01 · FY2003 · CA
Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer
$672,298Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · CA
Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer
$672,298Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr · U01 · FY2023 · CA
Targeting non-small cell lung cancer cells and the adverse tumor microenvironment with a small-molecule STAT3 inhibitor
$672,297David John Tweardy · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells
$672,271Sandra Aung · Ubivac, Llc · R44 · FY2011 · CA
PD-1/PD-L1 modulation in cancer therapy
$672,206Drew M. Pardoll · Johns Hopkins University · R01 · FY2020 · CA
Phagocytosis--Pulmonary Alveolar Macrophages
$672,190Thomas Peter Stossel · Brigham And Women'S Hospital · R01 · FY2006 · HL
Value of Information Methods for NHLBI Trials
$672,056Anirban Basu · University Of Washington · R01 · FY2016 · HL
The potential risks and benefits of electronic cigarettes to older smokers at high risk for lung cancer
$672,041Jason D Robinson · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA